Survivin Splice Variant 2β Enhances Pancreatic Ductal Adenocarcinoma Resistance to Gemcitabine

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal disease with poor prognosis, as it is difficult to predict or circumvent, and it develops chemoresistance quickly. One cellular mechanism associated with chemoresistance is alternative splicing dysfunction, a process through whic...

Descripción completa

Detalles Bibliográficos
Autores principales: Fuller, Ryan N, Kabagwira, Janviere, Vallejos, Paul A, Folkerts, Andrew D, Wall, Nathan R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553431/
https://www.ncbi.nlm.nih.gov/pubmed/36238134
http://dx.doi.org/10.2147/OTT.S341720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553431/
https://www.ncbi.nlm.nih.gov/pubmed/36238134
http://dx.doi.org/10.2147/OTT.S341720

Ejemplares similares